Journal article
Disease susceptibility to ST11 complex meningococci bearing serogroup C or W135 polysaccharide capsules, North America
- Abstract:
-
Clusters of meningococcal disease caused by a hyperinvasive lineage of Neisseria meningitidis, the ST11 complex, bearing a serogroup C polysaccharide capsule, have been prominent in Europe and North America since the early 1990s. This situation has led to expensive public health measures for outbreak control and, finally, to the introduction of a serogroup C glyconjugate vaccine into the primary immunization schedule in the United Kingdom and elsewhere. ST11 complex meningococci may ...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Authors
Funding
British Columbia Children's Hospital Telethon
More from this funder
Bibliographic Details
- Publisher:
- Department of Health and Human Services, Centers for Disease Control and Prevention Publisher's website
- Journal:
- Emerging Infectious Diseases Journal website
- Volume:
- 10
- Issue:
- 10
- Pages:
- 1812-1815
- Publication date:
- 2004-10-01
- ISSN:
-
1080-6059
Item Description
- Language:
- English
- Keywords:
- Subjects:
- UUID:
-
uuid:13994fc2-4770-4fdf-943b-cfb239b470be
- Local pid:
- ora:4231
- Deposit date:
- 2010-10-11
Related Items
Terms of use
- Copyright holder:
- Public Domain
- Copyright date:
- 2004
- Notes:
- Citation: Pollard AJ, Ochnio J, Ho M, Callaghan M, Bigham M & Dobson S. Disease susceptibility to ST11 complex meningococci bearing serogroup C or W135 polysaccharide capsules, North America. Emerg Infect Dis [serial on the Internet]. 2004 Oct. Available from http://www.cdc.gov/ncidod/EID/vol10no10/04-0335.htm.
If you are the owner of this record, you can report an update to it here: Report update to this record